Manufacturer record

IBN Herbals (A unit of curetech formulation (P) Ltd) Khasara No. 63: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

2 batches manufactured by IBN Herbals (A unit of curetech formulation (P) Ltd) Khasara No. 63 (Himachal Pradesh) were declared Not of Standard Quality between November 2025 and April 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

2 records linked to IBN Herbals (A unit of curetech formulation (P) Ltd) Khasara No. 63 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
2Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Nov 2025 to Apr 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

2
NSQ batches since 2025
2
Products affected
Disintegration
Most common failure
Apr 2026
Latest alert

Flagged batches per year

2025 · 12026 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Ibuprofen And Paracetamol Tablets IP ISW24176Mfg 2024-08 · Exp 2027-07 DisintegrationDisintegration DTL, PuducherryState lab Apr 2026
Paracetamol Tablets IP 500 GPL23033Mfg 2023-08 · Exp 2026-07 Test for DissolutionDissolution RDTL, Bellary, KarnatakaState lab Nov 2025

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.